Product Name

  • Name

    10-Hydroxycamptothecin

  • EINECS 805-668-4
  • CAS No. 19685-09-7
  • Article Data22
  • CAS DataBase
  • Density 1.6 g/cm3
  • Solubility
  • Melting Point 265-270 °C
  • Formula C20H16N2O5
  • Boiling Point 820.7 °C at 760 mmHg
  • Molecular Weight 364.357
  • Flash Point 450.1 °C
  • Transport Information
  • Appearance Yellow solid
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 19685-09-7 (10-Hydroxycamptothecin)
  • Hazard Symbols IrritantXi
  • Synonyms 10-Hydroxy-CPT;Camptothecin, hydroxy-;1H-Pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrate, (S)-;(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;Camptothecine, 10-hydroxy- (8CI);Hydroxycamptothecine;1H-Pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)- (9CI);
  • PSA 101.65000
  • LogP 1.78520

Synthetic route

camptothecin
7689-03-4

camptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Stage #1: camptothecin With hydrogen; acetic acid; platinum(IV) oxide
Stage #2: With lead(IV) acetate; acetic acid
51%
Yield given. Multistep reaction;
With sulfuric acid; dihydrogen peroxide; acetic acid 2) irradiation; Yield given. Multistep reaction;
10-methoxycamptothecin
19685-10-0

10-methoxycamptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
With hydrogen bromide at 110℃; for 72h;82%
With hydrogen bromide In water at 110℃; for 7h; Inert atmosphere; optical yield given as %ee;80%
With hydrogen bromide In water at 100℃; Sealed tube;80%
With hydrogen bromide72%
With hydrogen bromide In water for 2h; Reflux;
camptothecin
7689-03-4

camptothecin

A

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

B

(S)-9-acetoxy-4-ethyl-4-hydroxy-1,12-dihydro-4H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione
19685-11-1

(S)-9-acetoxy-4-ethyl-4-hydroxy-1,12-dihydro-4H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione

Conditions
ConditionsYield
Stage #1: camptothecin With hydrogen; acetic acid; platinum under 760.051 Torr; for 8.5h;
Stage #2: With lead(IV) acetate In acetic acid Heating / reflux;
1,2,6,7-tetrahydro-(20S)-camphthotecine
870527-52-9

1,2,6,7-tetrahydro-(20S)-camphthotecine

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
With [bis(acetoxy)iodo]benzene; water In acetic acid Yield given;
With [bis(acetoxy)iodo]benzene; acetic acid
In acetic acid at 20℃;
With [bis(acetoxy)iodo]benzene; acetic acid In water at 20℃; for 18h; Large scale reaction;1.36 kg
tetrahydrocamptothecin acetate

tetrahydrocamptothecin acetate

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Stage #1: tetrahydrocamptothecin acetate With [bis(acetoxy)iodo]benzene In water; acetic acid at 27.5℃; for 18h;
Stage #2: With methanol In N,N-dimethyl-formamide at 27.5 - 76.5℃; for 6h;
10-hydroxycamptothecin

10-hydroxycamptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
In 1,4-dioxane; acetonitrile for 0.75h; UV-irradiation;98.5%
9-<(dimethylamino)methyl>-10-hydroxy-(20S)-camptothecin acetate salt
123948-88-9

9-<(dimethylamino)methyl>-10-hydroxy-(20S)-camptothecin acetate salt

A

(S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-12-methylene-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
942429-91-6

(S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-12-methylene-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione

B

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C

Topotecan hydrochloride
119413-54-6, 123949-07-5

Topotecan hydrochloride

D

camptothecin
7689-03-4

camptothecin

Conditions
ConditionsYield
With hydrogenchloride In water for 0.25h;A < 0.04 %Chromat.
B < 0.001 %Chromat.
C 99.65 %Chromat.
D < 0.009 %Chromat.
1,2,6,7-tetrahydrocamptothecin
53544-22-2, 142696-57-9, 142696-58-0

1,2,6,7-tetrahydrocamptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 98 percent / pyridine / 1 h / 70 °C
2: 96.3 percent / H2SO4, conc. aq. HNO3 / 1 h
3: 82.3 percent / 20percent aq. H2SO4 / 2 h / Heating
4: 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) / dioxane / 2 h / Heating
5: 96.2 percent / H2 / PtO2 / ethanol; dioxane / 2 h / 760 Torr
6: 1.) 20percent aq. H2SO4, aq. NaNO2, 2.) H2O / 1.) 0-5 deg C, 15 min, 2.) reflux, 1 h
View Scheme
Multi-step reaction with 3 steps
1: 12 percent / Pb(OAc)4, trifluoroacetic acid / 0.25 h / Ambient temperature
2: 90.6 percent / 30percent aq. H2O2, acetic acid / 3.5 h / 70 - 80 °C
3: 22.5 percent / 1 N H2SO4 / dioxane / 0.5 h / Irradiation
View Scheme
Multi-step reaction with 3 steps
1: 12 percent / Pb(OAc)4, trifluoroacetic acid / 0.25 h / Ambient temperature
2: 90.6 percent / 30percent aq. H2O2, acetic acid / 3.5 h / 70 - 80 °C
3: 25 percent / 1 N aq. H2SO4 / dioxane / 0.5 h / Irradiation
View Scheme
Multi-step reaction with 3 steps
1: 12 percent / Pb(OAc)4, trifluoroacetic acid / 0.25 h / Ambient temperature
2: 90.6 percent / 30percent aq. H2O2, acetic acid / 3.5 h / 70 - 80 °C
3: 58 percent / 1 N aq. H2SO4 / dioxane / 0.5 h / Irradiation
View Scheme
2-[2,2-Dimethoxy-eth-(Z)-ylidene]-malonic acid benzyl ester methyl ester
161681-84-1

2-[2,2-Dimethoxy-eth-(Z)-ylidene]-malonic acid benzyl ester methyl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: LDA / tetrahydrofuran / -78 up to -20 deg C
2: H2 / 5percent Pd/C / methanol
3: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
4: TFA / H2O; toluene
5: DDQ
6: diisobutylaluminum hydride (DIBAH) / CH2Cl2
7: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
8: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 8 steps
1: LDA / tetrahydrofuran / -78 up to -20 deg C
2: H2 / 5percent Pd/C / methanol
3: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
4: TFA / H2O; toluene
5: DDQ
6: diisobutylaluminum hydride (DIBAH) / CH2Cl2
7: NaBH4 / methanol
8: 72 percent / 48percent HBr
View Scheme
2-[1-((2R,4S)-2-tert-Butyl-4-ethyl-5-oxo-[1,3]dioxolan-4-yl)-2,2-dimethoxy-ethyl]-malonic acid benzyl ester methyl ester

2-[1-((2R,4S)-2-tert-Butyl-4-ethyl-5-oxo-[1,3]dioxolan-4-yl)-2,2-dimethoxy-ethyl]-malonic acid benzyl ester methyl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: H2 / 5percent Pd/C / methanol
2: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
3: TFA / H2O; toluene
4: DDQ
5: diisobutylaluminum hydride (DIBAH) / CH2Cl2
6: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
7: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 7 steps
1: H2 / 5percent Pd/C / methanol
2: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
3: TFA / H2O; toluene
4: DDQ
5: diisobutylaluminum hydride (DIBAH) / CH2Cl2
6: NaBH4 / methanol
7: 72 percent / 48percent HBr
View Scheme
(S)-4-ethyl-4-hydroxy-6-iodo-3-oxo-1H-pyrano[3,4-c]-8-pyridone
173442-34-7

(S)-4-ethyl-4-hydroxy-6-iodo-3-oxo-1H-pyrano[3,4-c]-8-pyridone

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 78 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide / 1.) 0 deg C, 10 min; r.t., 15 min, 2.) toluene, 70 deg C, 20 h
2: 51 percent / Me6Sn2 / benzene / 5 h / 70 °C / Irradiation
3: 82 percent / aq. HBr / 72 h / 110 °C
View Scheme
Multi-step reaction with 2 steps
1: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
2: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
(S)-4-ethyl-4-hydroxy-6-iodo-8-methoxy-1,4-dihydro-pyrano[3,4-c]pyridin-3-one
174092-79-6

(S)-4-ethyl-4-hydroxy-6-iodo-8-methoxy-1,4-dihydro-pyrano[3,4-c]pyridin-3-one

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 73 percent / Me3SiCl, NaI / acetonitrile; H2O / 5 h / 65 °C
2: 78 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide / 1.) 0 deg C, 10 min; r.t., 15 min, 2.) toluene, 70 deg C, 20 h
3: 51 percent / Me6Sn2 / benzene / 5 h / 70 °C / Irradiation
4: 82 percent / aq. HBr / 72 h / 110 °C
View Scheme
Multi-step reaction with 3 steps
1: 72 percent / aq. HI
2: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
3: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
Camptothecin 1-oxide
86639-48-7

Camptothecin 1-oxide

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 11.5 percent / 1 N aq. H2SO4 / dioxane / 0.5 h / Irradiation
2: H2, acetic acid / PtO2 / dioxane / 760 Torr
3: 98 percent / pyridine / 1 h / 70 °C
4: 96.3 percent / H2SO4, conc. aq. HNO3 / 1 h
5: 82.3 percent / 20percent aq. H2SO4 / 2 h / Heating
6: 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) / dioxane / 2 h / Heating
7: 96.2 percent / H2 / PtO2 / ethanol; dioxane / 2 h / 760 Torr
8: 1.) 20percent aq. H2SO4, aq. NaNO2, 2.) H2O / 1.) 0-5 deg C, 15 min, 2.) reflux, 1 h
View Scheme
Multi-step reaction with 3 steps
1: 11.5 percent / 1 N aq. H2SO4 / dioxane / 0.5 h / Irradiation
2: H2, acetic acid / PtO2 / dioxane / 760 Torr
3: 73.5 percent / Pb(OAc)4, trifluoroacetic acid / 0.25 h / Ambient temperature
View Scheme
Camptothecin 1-oxide
86639-48-7

Camptothecin 1-oxide

A

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

B

((S)-4-Ethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-ylsulfanyl)-acetic acid ethyl ester
86639-49-8

((S)-4-Ethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-ylsulfanyl)-acetic acid ethyl ester

Conditions
ConditionsYield
With sulfuric acid In 1,4-dioxane for 0.5h; Irradiation;A 58%
B 11.9%
10-nitro-(20S)-camptothecin
86639-62-5

10-nitro-(20S)-camptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 96.2 percent / H2 / PtO2 / ethanol; dioxane / 2 h / 760 Torr
2: 1.) 20percent aq. H2SO4, aq. NaNO2, 2.) H2O / 1.) 0-5 deg C, 15 min, 2.) reflux, 1 h
View Scheme

N,20-O-diacetyl-1,2,6,7-tetrahydrocamptothecin

N,20-O-diacetyl-1,2,6,7-tetrahydrocamptothecin

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 96.3 percent / H2SO4, conc. aq. HNO3 / 1 h
2: 82.3 percent / 20percent aq. H2SO4 / 2 h / Heating
3: 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) / dioxane / 2 h / Heating
4: 96.2 percent / H2 / PtO2 / ethanol; dioxane / 2 h / 760 Torr
5: 1.) 20percent aq. H2SO4, aq. NaNO2, 2.) H2O / 1.) 0-5 deg C, 15 min, 2.) reflux, 1 h
View Scheme
Acetic acid (4R,5bS,11aS)-4-acetoxy-4-ethyl-9-nitro-3,13-dioxo-3,4,5b,11a,12,13-hexahydro-1H,11H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-6-yl ester

Acetic acid (4R,5bS,11aS)-4-acetoxy-4-ethyl-9-nitro-3,13-dioxo-3,4,5b,11a,12,13-hexahydro-1H,11H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-6-yl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 82.3 percent / 20percent aq. H2SO4 / 2 h / Heating
2: 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) / dioxane / 2 h / Heating
3: 96.2 percent / H2 / PtO2 / ethanol; dioxane / 2 h / 760 Torr
4: 1.) 20percent aq. H2SO4, aq. NaNO2, 2.) H2O / 1.) 0-5 deg C, 15 min, 2.) reflux, 1 h
View Scheme
(S)-4-ethyl-4-hydroxy-6-iodo-7-(prop-2-yn-1-yl)-1,7-dihydro-3H-pyrano[3,4-c]pyridino-3,8(4H)-dione
174092-80-9

(S)-4-ethyl-4-hydroxy-6-iodo-7-(prop-2-yn-1-yl)-1,7-dihydro-3H-pyrano[3,4-c]pyridino-3,8(4H)-dione

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 51 percent / Me6Sn2 / benzene / 5 h / 70 °C / Irradiation
2: 82 percent / aq. HBr / 72 h / 110 °C
View Scheme

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 45 percent / ICl / CCl4; CH2Cl2 / 48 h / Ambient temperature
2: 73 percent / Me3SiCl, NaI / acetonitrile; H2O / 5 h / 65 °C
3: 78 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide / 1.) 0 deg C, 10 min; r.t., 15 min, 2.) toluene, 70 deg C, 20 h
4: 51 percent / Me6Sn2 / benzene / 5 h / 70 °C / Irradiation
5: 82 percent / aq. HBr / 72 h / 110 °C
View Scheme
2-methoxy-6-(trimethylsilyl)pyridine
170453-55-1

2-methoxy-6-(trimethylsilyl)pyridine

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: tBuLi
2: nBuLi, I2
3: 63 percent / Et3SiH / trifluoroacetic acid
4: 69 percent / K2CO3, Bu4NBr / Pd(OAc)2
5: 1.) OsO4, (DHQD)2-Pyr, 2.) I2, CaCO3
6: 47 percent / ICl
7: 72 percent / aq. HI
8: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
9: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
2-Methoxy-6-trimethylsilanyl-pyridine-3-carbaldehyde
453518-21-3

2-Methoxy-6-trimethylsilanyl-pyridine-3-carbaldehyde

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: nBuLi, I2
2: 63 percent / Et3SiH / trifluoroacetic acid
3: 69 percent / K2CO3, Bu4NBr / Pd(OAc)2
4: 1.) OsO4, (DHQD)2-Pyr, 2.) I2, CaCO3
5: 47 percent / ICl
6: 72 percent / aq. HI
7: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
8: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
4-iodo-2-methoxy-6-trimethylsilanyl-3-pyridinecarboxaldehyde
174092-75-2

4-iodo-2-methoxy-6-trimethylsilanyl-3-pyridinecarboxaldehyde

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 63 percent / Et3SiH / trifluoroacetic acid
2: 69 percent / K2CO3, Bu4NBr / Pd(OAc)2
3: 1.) OsO4, (DHQD)2-Pyr, 2.) I2, CaCO3
4: 47 percent / ICl
5: 72 percent / aq. HI
6: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
7: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
3-[((E)-But-2-enyl)oxymethyl]-4-iodo-2-methoxy-6-trimethylsilanyl-pyridine

3-[((E)-But-2-enyl)oxymethyl]-4-iodo-2-methoxy-6-trimethylsilanyl-pyridine

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 69 percent / K2CO3, Bu4NBr / Pd(OAc)2
2: 1.) OsO4, (DHQD)2-Pyr, 2.) I2, CaCO3
3: 47 percent / ICl
4: 72 percent / aq. HI
5: 88 percent / NaH, LiBr / 1,2-dimethoxy-ethane; dimethylformamide
6: Me3SnSnMe3 / benzene / 70 °C / Irradiation
View Scheme
(S)-4-ethyl-4-hydroxy-6-iodo-7-(prop-2-yn-1-yl)-1,7-dihydro-3H-pyrano[3,4-c]pyridino-3,8(4H)-dione
174092-80-9

(S)-4-ethyl-4-hydroxy-6-iodo-7-(prop-2-yn-1-yl)-1,7-dihydro-3H-pyrano[3,4-c]pyridino-3,8(4H)-dione

4-isocyanophenol
162471-15-0

4-isocyanophenol

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
With hexamethyldistannane In benzene at 70℃; Irradiation;
Camptothecin 1-oxide
86639-48-7

Camptothecin 1-oxide

acetic acid
64-19-7

acetic acid

A

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

B

(S)-9-acetoxy-4-ethyl-4-hydroxy-1,12-dihydro-4H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione
19685-11-1

(S)-9-acetoxy-4-ethyl-4-hydroxy-1,12-dihydro-4H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione

Conditions
ConditionsYield
With sulfuric acid In 1,4-dioxane for 0.5h; Irradiation;A 25%
B 30.5%
7-Methoxy-1,3-dihydro-pyrrolo[3,4-b]quinoline-2-carboxylic acid methyl ester
161681-89-6

7-Methoxy-1,3-dihydro-pyrrolo[3,4-b]quinoline-2-carboxylic acid methyl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 30percent HBr/HOAc / 12 h / 20 °C
2: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
3: TFA / H2O; toluene
4: DDQ
5: diisobutylaluminum hydride (DIBAH) / CH2Cl2
6: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
7: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 7 steps
1: 30percent HBr/HOAc / 12 h / 20 °C
2: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
3: TFA / H2O; toluene
4: DDQ
5: diisobutylaluminum hydride (DIBAH) / CH2Cl2
6: NaBH4 / methanol
7: 72 percent / 48percent HBr
View Scheme
2-(Methoxycarbonyl-prop-2-ynyl-amino)-N-(4-methoxy-phenyl)-acetimidic acid methyl ester

2-(Methoxycarbonyl-prop-2-ynyl-amino)-N-(4-methoxy-phenyl)-acetimidic acid methyl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: acetonitrile / 50 °C
2: 30percent HBr/HOAc / 12 h / 20 °C
3: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
4: TFA / H2O; toluene
5: DDQ
6: diisobutylaluminum hydride (DIBAH) / CH2Cl2
7: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
8: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 8 steps
1: acetonitrile / 50 °C
2: 30percent HBr/HOAc / 12 h / 20 °C
3: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
4: TFA / H2O; toluene
5: DDQ
6: diisobutylaluminum hydride (DIBAH) / CH2Cl2
7: NaBH4 / methanol
8: 72 percent / 48percent HBr
View Scheme
2-[1-((2R,4S)-2-tert-Butyl-4-ethyl-5-oxo-[1,3]dioxolan-4-yl)-2,2-dimethoxy-ethyl]-malonic acid monomethyl ester

2-[1-((2R,4S)-2-tert-Butyl-4-ethyl-5-oxo-[1,3]dioxolan-4-yl)-2,2-dimethoxy-ethyl]-malonic acid monomethyl ester

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
2: TFA / H2O; toluene
3: DDQ
4: diisobutylaluminum hydride (DIBAH) / CH2Cl2
5: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
6: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 6 steps
1: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
2: TFA / H2O; toluene
3: DDQ
4: diisobutylaluminum hydride (DIBAH) / CH2Cl2
5: NaBH4 / methanol
6: 72 percent / 48percent HBr
View Scheme
7-Methoxy-2,3-dihydro-1H-pyrrolo[3,4-b]quinoline; hydrobromide

7-Methoxy-2,3-dihydro-1H-pyrrolo[3,4-b]quinoline; hydrobromide

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
2: TFA / H2O; toluene
3: DDQ
4: diisobutylaluminum hydride (DIBAH) / CH2Cl2
5: 1.) NaBH4; 2.) aq. NaOH / 1.) MeOH
6: 72 percent / 48percent HBr
View Scheme
Multi-step reaction with 6 steps
1: 89 percent / 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzotriazole (HOBT), Et3N / tetrahydrofuran
2: TFA / H2O; toluene
3: DDQ
4: diisobutylaluminum hydride (DIBAH) / CH2Cl2
5: NaBH4 / methanol
6: 72 percent / 48percent HBr
View Scheme
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

10-methoxycamptothecin
19685-10-0

10-methoxycamptothecin

Conditions
ConditionsYield
In 1,4-dioxane; methanol at 20℃; for 2h;100%
88%
In 1,4-dioxane; methanol; diethyl ether for 1h; Ambient temperature;87.5%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

4-piperidinopiperidine-1-carbonyl chloride
103816-19-9

4-piperidinopiperidine-1-carbonyl chloride

10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin
103816-16-6

10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 4h;100%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

9-bromo-10-hydroxycamptothecin
1097323-11-9

9-bromo-10-hydroxycamptothecin

Conditions
ConditionsYield
With N-Bromosuccinimide In N,N-dimethyl-formamide at 0 - 20℃; for 2h;98%
With N-Bromosuccinimide In N,N-dimethyl-formamide95%
N,N-phenylbistrifluoromethane-sulfonimide
37595-74-7

N,N-phenylbistrifluoromethane-sulfonimide

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

10-hydroxy-(20S)-camptothecin trifluoromethanesulfonate
123949-09-7

10-hydroxy-(20S)-camptothecin trifluoromethanesulfonate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 23 - 50℃; Inert atmosphere;97%
With triethylamine In N,N-dimethyl-formamide at 23 - 50℃;97%
With triethylamine In N,N-dimethyl-formamide at 20℃;96.7%
With triethylamine In N,N-dimethyl-formamide at 50℃; for 3h;
With triethylamine In N,N-dimethyl-formamide at 50℃;
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

9-iodine-10-hydroxycamptothecin
1256544-04-3

9-iodine-10-hydroxycamptothecin

Conditions
ConditionsYield
With N-iodo-succinimide In N,N-dimethyl-formamide at 0 - 20℃; for 2h;97%
With N-iodo-succinimide In N,N-dimethyl-formamide at 0 - 20℃; for 2h;95%
1-chlorocarbonyl-4-piperidinopiperidine hydrochloride

1-chlorocarbonyl-4-piperidinopiperidine hydrochloride

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin hydrochloride

10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin hydrochloride

Conditions
ConditionsYield
With potassium carbonate; triethylamine In acetonitrile at 60℃; for 6h;97%
glutaric anhydride,
108-55-4

glutaric anhydride,

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C25H22N2O8

C25H22N2O8

Conditions
ConditionsYield
With pyridine at 25℃; for 72h;97%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

2-Methylpropionic anhydride
97-72-3

2-Methylpropionic anhydride

camptothecin 10,20-di-O-isobutyrate

camptothecin 10,20-di-O-isobutyrate

Conditions
ConditionsYield
sulfuric acid at 20 - 100℃; for 16h;96%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

10-hydroxy-mappicine ketone

10-hydroxy-mappicine ketone

Conditions
ConditionsYield
In various solvent(s) at 200℃; for 9h;95%
triethylsilyl chloride
994-30-9

triethylsilyl chloride

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

20(S)-O-triethylsilylcampothecin
1004265-03-5

20(S)-O-triethylsilylcampothecin

Conditions
ConditionsYield
Stage #1: (S)-10-hydroxycamptothecin With 1H-imidazole In N,N-dimethyl-formamide for 0.166667h; Inert atmosphere;
Stage #2: triethylsilyl chloride With dmap In N,N-dimethyl-formamide
94%
Stage #1: (S)-10-hydroxycamptothecin With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: triethylsilyl chloride With dmap In N,N-dimethyl-formamide at 20℃; for 60h; Inert atmosphere;
94%
With 1H-imidazole; dmap In N,N-dimethyl-formamide for 24.1667h;94%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

10-tert-butoxycarbonyloxycamptothecin
362496-88-6

10-tert-butoxycarbonyloxycamptothecin

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 20℃;94%
With pyridine In N,N-dimethyl-formamide at 20℃;
With pyridine In N,N-dimethyl-formamide at 20℃;2.1 g
With pyridine In dichloromethane
In pyridine; N,N-dimethyl-formamide at 20℃; Inert atmosphere;
glutaric anhydride,
108-55-4

glutaric anhydride,

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C25H22N2O8
1353778-70-7

C25H22N2O8

Conditions
ConditionsYield
With pyridine at 20℃; for 48h;94%
With pyridine at 20℃;59.22%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

4-nitrophenyl camptothecin-10-yl carbonate
656233-42-0

4-nitrophenyl camptothecin-10-yl carbonate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 1h; Schlenk technique;93%
With triethylamine In tetrahydrofuran at 0 - 20℃; for 1h;93%
With triethylamine at 20℃; for 1h;91%

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C39H50N4O12
945867-58-3

C39H50N4O12

Conditions
ConditionsYield
With triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 2h;92%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Cyclohexanecarboxylic acid

Cyclohexanecarboxylic acid

(S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl cyclohexanecarboxylate

(S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl cyclohexanecarboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;92%

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

Topotecan hydrochloride
119413-54-6, 123949-07-5

Topotecan hydrochloride

Conditions
ConditionsYield
In propan-1-ol; dichloromethane91%
formaldehyd
50-00-0

formaldehyd

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

(S)-1-Pyrrolidin-2-yl-methanol

(S)-1-Pyrrolidin-2-yl-methanol

10-hydroxyl-9-L-prolinol (+)methylcamptothecin
1439356-77-0

10-hydroxyl-9-L-prolinol (+)methylcamptothecin

Conditions
ConditionsYield
In acetic acid at 40 - 90℃; Mannich Aminomethylation;90.2%
methanol
67-56-1

methanol

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

7-hydroxymethyl-10-hydroxycamptothecin
86639-61-4

7-hydroxymethyl-10-hydroxycamptothecin

Conditions
ConditionsYield
With sulfuric acid; dihydrogen peroxide; iron(II) sulfate at 20℃; for 96h; hydroxymethylation;90%
2-(hydroxymethyl)-1H-isoindole-1,3(2H)-dione
118-29-6

2-(hydroxymethyl)-1H-isoindole-1,3(2H)-dione

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C29H21N3O7
1352172-54-3

C29H21N3O7

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 12h;90%
N-hydroxymethyl-3,4,5,6-tetrahydrophthalimide
4887-42-7

N-hydroxymethyl-3,4,5,6-tetrahydrophthalimide

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C29H25N3O7
1352172-55-4

C29H25N3O7

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 12h;90%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

prenyl bromide
870-63-3

prenyl bromide

(S)-4-ethyl-4-hydroxy-9-((3-methylbut-2-en-1-yl)oxy)-1,12-dihydro-14H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

(S)-4-ethyl-4-hydroxy-9-((3-methylbut-2-en-1-yl)oxy)-1,12-dihydro-14H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

Conditions
ConditionsYield
With potassium carbonate In acetone for 3h; Reflux;90%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

carbonic acid 4-ethoxycarbonyloxy-4-ethyl-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester ethyl ester

carbonic acid 4-ethoxycarbonyloxy-4-ethyl-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester ethyl ester

Conditions
ConditionsYield
With pyridine In 1,2-dichloro-ethane89.2%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

poly(ethylene glycol)-O-glycolic acid ether

poly(ethylene glycol)-O-glycolic acid ether

10-camptothecin-[poly(ethylene glycol)-O-glycolic acid ether] ester, Mw=40000

10-camptothecin-[poly(ethylene glycol)-O-glycolic acid ether] ester, Mw=40000

Conditions
ConditionsYield
With pyridine; O-phenyl phosphorodichloridate In chloroform at 20℃; for 18h;89%
C21H38N2O8
945867-57-2

C21H38N2O8

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C41H54N4O13
945867-59-4

C41H54N4O13

Conditions
ConditionsYield
With triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 2h;89%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

camptothecin 10,20-di-O-butyrate

camptothecin 10,20-di-O-butyrate

Conditions
ConditionsYield
sulfuric acid at 20 - 100℃;89%
1,3,6,9,12-pentaoxa-2-thiacyclotetradecane 2,2-dioxide

1,3,6,9,12-pentaoxa-2-thiacyclotetradecane 2,2-dioxide

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C28H32N2O9

C28H32N2O9

Conditions
ConditionsYield
Stage #1: 1,3,6,9,12-pentaoxa-2-thiacyclotetradecane 2,2-dioxide; (S)-10-hydroxycamptothecin With potassium carbonate In N,N-dimethyl-formamide at 40℃;
Stage #2: With sulfuric acid In tetrahydrofuran; water for 3h; Reflux;
89%
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

allyl bromide
106-95-6

allyl bromide

10-allyloxycamptothecin
185425-24-5

10-allyloxycamptothecin

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; Inert atmosphere;88.2%
With potassium carbonate In N,N-dimethyl-formamide
C10H20O8S

C10H20O8S

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C30H36N2O10

C30H36N2O10

Conditions
ConditionsYield
Stage #1: C10H20O8S; (S)-10-hydroxycamptothecin With potassium carbonate In N,N-dimethyl-formamide at 40℃;
Stage #2: With sulfuric acid In tetrahydrofuran; water for 3h; Reflux;
88%
C18H36O12S

C18H36O12S

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

C38H52N2O14

C38H52N2O14

Conditions
ConditionsYield
Stage #1: C18H36O12S; (S)-10-hydroxycamptothecin With potassium carbonate In N,N-dimethyl-formamide at 40℃;
Stage #2: With sulfuric acid In tetrahydrofuran; water for 3h; Reflux;
88%

(S)-10-Hydroxycamptothecin Chemical Properties


Product Name: 10-Hydroxycamptothecin 
Molecular Weight: 364.35144 [g/mol]
Molecular Formula: C20H16N2O5
XLogP3-AA: 0.6
H-Bond Donor: 2
H-Bond Acceptor: 6 
Index of Refraction: 1.776
Molar Refractivity: 94.97 cm3
Molar Volume: 227 cm3
Surface Tension: 92.4 dyne/cm
Density: 1.6 g/cm3
Flash Point: 450.1 °C
Enthalpy of Vaporization: 125.05 kJ/mol
Boiling Point: 820.7 °C at 760 mmHg
Vapour Pressure: 1.67E-28 mmHg at 25 °C
Appearance: Yellow Solid
Melting Point: 265-270 °C
Classification Code of (S)-10-Hydroxycamptothecin (CAS NO.19685-09-7): Drug / Therapeutic Agent; Mutation data; Natural Product 
Product Categories: Alkaloids; INTERMEDIATESOFIRINOTECANHCLTRIHYDRATE; Camptothecin series; Natural Plant Extract; Chiral Reagents; Intermediates & Fine Chemicals; Pharmaceuticals; Natural Anti-cancer Medical Materials and It's Derivatives

(S)-10-Hydroxycamptothecin Uses

 (S)-10-Hydroxycamptothecin (CAS NO.19685-09-7) is used in the treatment of cancer. It is used to synthesis 7-Ethyl-10-Hydroxy-CPT,SN-38 .

(S)-10-Hydroxycamptothecin Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 104mg/kg (104mg/kg)   Drugs of the Future. Vol. 7, Pg. 629, 1982.
rat LD intravenous > 10mg/kg (10mg/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED

KIDNEY, URETER, AND BLADDER: HEMATURIA
Cancer Chemotherapy and Pharmacology. Vol. 41, Pg. 257, 1998.

(S)-10-Hydroxycamptothecin Safety Profile

Safety Information of (S)-10-Hydroxycamptothecin (CAS NO.19685-09-7):
Hazard Codes:Xi  
Risk Statements:36/37/38
36/37/38:Irritating to eyes, respiratory system and skin 
Safety Statements:26-36
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36:Wear suitable protective clothing   
WGK Germany:3

(S)-10-Hydroxycamptothecin Specification

 (S)-10-Hydroxycamptothecin (CAS NO.19685-09-7), its Synonyms are (S)-10-Hydroxycamptothecin hydrate ; 10-Hydroxycamptothecin ; 10-Hydroxycamptothecine ; Camptothecin, 10-hydroxy- ; Camptothecin, hydroxy- ; Hydroxycamptothecin ; Hydroxycamptothecine ; 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrate, (S)- ; 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)- (9CI) ; Camptothecine, 10-hydroxy- (8CI) .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View